A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency

Clinical trial NCT06565078 · RECRUITING

Trial details

NCT number: NCT06565078
Sponsor: Takeda
Status: RECRUITING
Study type: OBSERVATIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2025-02-17
Primary completion: 2030-03-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.